论文信息 - Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial - 字舞流文

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Jin-hai Tang | Junjie Li | Keda Yu | Bing-he Xu | Q. Sun | Z. Shao | D. Pang | Z. Fan | Y. Sheng | Yali Cao | Jun Jiang | O. Wang | P. He | Hongwei Zhang | Xijing Wang | Shui Wang | Jian-guo Zhang | Jianfeng Wang | Jianfeng Wang | Feng Jin | P. Fu | Shi-ping Yu | M. Mo | B. Ma | G. Ren | Jiandong Wang | Yunjiang Liu | X. Qu | S. Cui | Pengxi Liu | Guojun Zhang | Suisheng Yang | Jin Zhang | Z. Zhuang | Xiaofeng Guo | Jin Zhang | Changqing Wang | Q. He | Xinzheng Li | Guoqin Jiang | N. Rao | Peng-xi Liu